IQVIA was previously known as Quintiles Transnational Holdings Inc. before undergoing a massive merger with IMS Health Holdings. Following the completion of this strategic combination, the newly unified enterprise initially operated under the corporate title Quintiles IMS Holdings before officially rebranding itself globally as IQVIA. This corporate evolution combined extensive clinical trial execution capabilities with advanced healthcare data analytics, real-world research insights, and commercial technology solutions.